Article By:
Sweta Killa
Wednesday, May 1, 2024 1:55 PM EDT
Eli Lilly and Company posted mixed first-quarter 2024 earnings, beating earnings estimates but lagging on revenues. Investors seeking to tap the opportune moment could bet on ETFs having the largest exposure to the drugmaker.